PLAYBOOK · NUTRA · UK / EU
Card Acquiring for UK / EU Nutraceutical Brands
Novel Foods & EFSA Compliance
Selling supplements into the UK and EU means card acquirers will read your ingredient deck against the EU Novel Foods Regulation (2015/2283) and the FSA's Great Britain novel foods list. Ingredients without a positive EFSA opinion or an FSA authorisation route are the single biggest reason underwriting stalls — even when chargebacks and refund ratios look clean.
WHY THIS COMBINATION IS HARD
What goes wrong when generalist acquirers see this profile.
Novel Foods ingredient screening
Acquirer underwriting now reads SKUs against the EU Union list of novel foods and the FSA's CBD public list. An ingredient like NMN, 6-paradol, or a concentrated botanical isolate without a validated EFSA application or FSA authorisation route is a hard decline — regardless of the merchant's processing history.
VAMP exposure on subscription/auto-ship models
Most nutra economics depend on auto-replenishment, which historically attracts dispute reason codes 13.2 (cancelled recurring) and 10.4 (other fraud). Under the consolidated Visa Acquirer Monitoring Program, count-based ratios make supplements one of the categories acquirers actively portfolio-manage to stay under threshold.
Health claim and pre-checkout copy review
EU Regulation 1924/2006 on nutrition and health claims, plus the UK's parallel regime, mean acquirers screen landing pages for unapproved disease claims, before/after imagery and 'clinically proven' language. A non-compliant claim on a sales funnel can trigger MATCH listing or termination, even if the product itself is legal.
MCC misclassification risk
Generalist acquirers often try to board nutra under 5499 (Misc Food Stores) or 5814 (Fast Food) to keep fees low. Scheme reclassification to 5912 (Drug Stores), 5122 (Drugs, Druggists' Sundries) or 7298 (Health & Beauty) mid-cycle exposes the merchant to retroactive interchange and a higher dispute multiplier.
Cross-border IBAN and PSD2 friction
Brands routing UK settlement through an EU PSP (or vice-versa post-Brexit) increasingly hit IBAN discrimination complaints and SCA exemption mismatches on recurring transactions, both of which surface as fraud disputes rather than authentication failures.
Free-trial and negative-option historical baggage
Card schemes still treat free-trial-to-subscription nutra as one of the highest-watch flows after the FTC and CMA actions of the 2020s. New applicants inherit category-level scepticism even with a clean continuity model and clear cancellation paths.
WHAT TO EXPECT
Realistic terms for this combination.
ROLLING RESERVE
5-10% rolling over 180 days for compliant SKUs; 10-15% over 180 days for CBD, mushroom extracts or borderline novel-food ingredients
SETTLEMENT
T+3 to T+7, with T+14 not unusual on first 90 days
MCC CODES
5499, 5912, 5122, 8099, 7298
Scheme reporting: VAMP count-based ratio replacing VDMP/VFMP means subscription cancellation disputes count toward the same bucket as fraud. Misclassification between 5499 and 5912 is a frequent trigger for scheme reviews on nutra portfolios.
ACQUIRER LANDSCAPE
Who actually underwrites this combination.
The active pool for UK/EU nutra is dominated by EU credit institutions with documented health-and-wellness programmes, UK-licensed acquirers with high-risk desks that maintain a positive list of permitted ingredients, and a smaller set of specialist PSPs that have built Novel Foods screening into their onboarding. This pool differs from generalist acquirers in that they pre-clear SKUs against the Union list and FSA register, accept rolling reserves as a structural feature rather than a remediation step, and price chargeback ratios up to roughly 1% rather than declining at 0.65%.
HOW ICETREE APPROACHES IT
Our approach for merchants in this combination.
- We pre-screen your full SKU list against the EU Union list of novel foods and the FSA Great Britain register before any acquirer introduction, so non-compliant ingredients are flagged before underwriting sees them.
- We match you to acquirers with documented nutra programmes that price for subscription models rather than penalising them under VAMP.
- We negotiate reserve percentage and release schedule based on your actual chargeback ledger and refund policy, not the category default.
- We review your sales funnel and product page copy for Regulation 1924/2006 health-claim risk before submission, reducing back-and-forth on application.
- We structure multi-acquirer setups across UK and EU entities so you're not single-points-of-failure on one MID.
FAQ
Common questions answered.
Want IceTree on your side?
Run the Approval Predictor for a 2-minute estimate of your acquirer fit, expected reserve range, and what to prepare — specific to United Kingdom / EU and Novel Foods / EFSA.